“Success of GLP-1 receptor agonists in kidney disease halts FLOW trial early.”

Authors

Katherine Tuttle, ProvidenceFollow

Document Type

Presentation

Publication Date

5-1-2024

Keywords

washington; spokane

Clinical Institute

Kidney & Diabetes

Specialty/Research Institute

Endocrinology

Specialty/Research Institute

Nephrology

Comments

ADA